Efficacy and Safety of JMT101 Combined Wth Docetaxel / HB1801 in Patients With Squamous Cell Non-Small Cell Lung Cancer
Clinical trial NCT06319313 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06319313
- Sponsor
- Shanghai JMT-Bio Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-01
- Primary completion
- 2026-07-01
- Enrollment
- 534
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.